Amdocs Limited (NASDAQ:DOX – Get Free Report) has been assigned an average recommendation of “Buy” from the four research firms that are currently covering the company, MarketBeat reports. Four research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have covered the stock in the last year is $108.60.
DOX has been the subject of a number of analyst reports. StockNews.com raised Amdocs from a “buy” rating to a “strong-buy” rating in a report on Thursday. Barclays boosted their price target on Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, February 8th. Citigroup boosted their price target on Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, Jefferies Financial Group initiated coverage on Amdocs in a report on Friday, December 1st. They issued a “buy” rating and a $105.00 price target for the company.
Get Our Latest Analysis on DOX
Hedge Funds Weigh In On Amdocs
Amdocs Price Performance
Shares of NASDAQ DOX opened at $92.74 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market cap of $10.90 billion, a PE ratio of 19.86, a P/E/G ratio of 1.52 and a beta of 0.69. The business has a 50-day simple moving average of $90.94 and a two-hundred day simple moving average of $86.80. Amdocs has a fifty-two week low of $78.38 and a fifty-two week high of $99.75.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.16. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter last year, the company earned $1.33 earnings per share. The company’s quarterly revenue was up 5.0% on a year-over-year basis. As a group, equities analysts expect that Amdocs will post 5.87 EPS for the current fiscal year.
Amdocs Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be paid a dividend of $0.479 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.07%. This is an increase from Amdocs’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Wednesday, March 27th. Amdocs’s dividend payout ratio is presently 37.26%.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- What is a Special Dividend?
- MarketBeat Week in Review – 3/4 – 3/8
- 3 Warren Buffett Stocks to Buy Now
- What is a Microcap Stock? Everything You Need to Know
- Trading Stocks: RSI and Why it’s Useful
- How to Invest in Casino Stocks: Pros and Cons and More
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.